ABLAbacus Life, Inc.

Nasdaq abacuslife.com


$ 10.09 $ 0.28 (2.82 %)    

Friday, 13-Sep-2024 15:58:36 EDT
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 10.2
$ 10.00 x 100
-- x --
-- - --
$ 5.75 - $ 13.25
51,423
na
761.44M
$ 0.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-25-2023 03-31-2023 10-Q
7 04-18-2023 12-31-2022 10-K
8 11-21-2022 09-30-2022 10-Q
9 08-22-2022 06-30-2022 10-Q
10 07-12-2022 03-31-2022 10-Q
11 06-22-2022 12-31-2021 10-K
12 02-26-2022 09-30-2021 10-Q
13 08-17-2021 06-30-2021 10-Q
14 07-30-2021 03-31-2021 10-Q
15 03-26-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 09-04-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-riley-securities-reiterates-buy-on-abacus-life-raises-price-target-to-16

B. Riley Securities analyst Matt Howlett reiterates Abacus Life (NASDAQ:ABL) with a Buy and raises the price target from $15...

 abacus-life-and-lorisco-life-announce-launch-of-preadisan-to-improve-health-predictions

New partnership leverages PREADISAN™, the cutting-edge health prediction platform using machine learning and modern proteomics ...

 abacus-life-q2-2024-adj-eps-018-beats-012-estimate-sales-29076m-beat-26162m-estimate

Abacus Life (NASDAQ:ABL) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.12 by 5...

 td-cowen-initiates-coverage-on-abacus-life-with-buy-rating-announces-price-target-of-14

TD Cowen analyst Andrew Kilgerman initiates coverage on Abacus Life (NASDAQ:ABL) with a Buy rating and announces Price Targe...

 abacus-life-announces-agreement-to-acquire-fcf-advisors-financial-terms-of-the-transaction-not-disclosed-deal-will-add-up-to-600m-in-aum-to-abacus

Acquisition accelerates expansion of ABL Wealth with a diverse suite of products Deal will add up to $600 million in AUM to Aba...

 abacus-life-says-remain-well-on-track-to-achieve-all-of-its-goals-for-2024

The company expects Q2 net income between $0.0 and $1.0 million, Adjusted EBITDA between $15.0 and $17.0 million. Jay Jackson,...

 piper-sandler-initiates-coverage-on-abacus-life-with-overweight-rating-announces-price-target-of-12

Piper Sandler analyst Crispin Love initiates coverage on Abacus Life (NASDAQ:ABL) with a Overweight rating and announces Pri...

 b-riley-securities-reiterates-buy-on-abacus-life-lowers-price-target-to-15

B. Riley Securities analyst Matt Howlett reiterates Abacus Life (NASDAQ:ABL) with a Buy and lowers the price target from $16...

 reported-earlier-abacus-life-prices-80m-public-offering-of-10m-common-stock-at-8share

The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expect...

 abacus-life-and-aimcor-announce-new-national-distribution-agreement-abacus-will-offer-their-expertise-and-become-a-preferred-partner-for-life-settlement-solutions-to-aimcors-national-network-of-affiliated-member-firms

Abacus Life, Inc. (NASDAQ:ABL) ("Abacus" or the "Company"), a pioneering alternative asset manager specializing...

 b-riley-securities-initiates-coverage-on-abacus-life-with-buy-rating-announces-price-target-of-16

B. Riley Securities analyst Matt Howlett initiates coverage on Abacus Life (NASDAQ:ABL) with a Buy rating and announces Pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION